 Forma Therapeutics Holdings Inc. FMTX, 1.67 announced Thursday and agreement to be acquired by Denmark-based Novo Nordisk NVO, 0.06 NOVO.B, -0.59 in a deal with an equity value of 1.1 billion. Forma shares are halted for news until 8:30 a.m. 